IGHE and anaphylaxis: Together, these experiments demonstrate that IL-2/JES6 administration that is first administered after mice have been sensitized does not affect allergen-specific IgE, but exacerbates anaphylaxis and increases the allergen-reactivity of IgE-sensitive effector cells, most likely mast cells.